Which of the following therapies is NOT recommended for long-term management of abnormal uterine bleeding?

The correct answer indicates that the copper intrauterine device (IUD) is not recommended for long-term management of abnormal uterine bleeding. The primary role of the copper IUD is as a form of contraception, and while it can create a local inflammatory response that may lead to heavier menstrual bleeding, it is not typically used to manage abnormal uterine bleeding over the long term. While some patients may experience changes in their menstrual patterns due to the copper IUD, it is known to sometimes exacerbate the very problem it is intended to help manage.

In contrast, hormonal contraceptives, the levonorgestrel intrauterine system, and tranexamic acid have established roles in the management of abnormal uterine bleeding. Hormonal contraceptives can effectively regulate menstrual cycles and reduce excessive bleeding. The levonorgestrel intrauterine system releases progestin, which softens the endometrial lining and significantly reduces menstrual blood loss, making it a suitable long-term option. Tranexamic acid is an antifibrinolytic agent that helps to reduce bleeding during menstruation and can be used as needed, but it is not considered a long-term management option like hormonal therapies.